CTOs on the Move


 
Founded in 2004, BioRx is a national provider of specialty pharmacy, infusion management and industry consulting services. As a private, independently-owned company, BioRx is committed to a flexible service model that meets the needs of its customers, including consumers, healthcare providers, health plans and pharmaceutical manufacturers. The company’s streamlined management structure allows it to respond more quickly to changes in the marketplace and provide a higher level of service that is customized for each consumer. Moreover, BioRx helps to provide a more cost-effective level of healthcare – in particular by moving patients from costly facility-based infusion sites to their homes, thereby ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.biorx.com
  • 10828 Kenwood Rd
    Cincinnati, OH USA 45242
  • Phone: 866.442.4679

Executives

Name Title Contact Details

Similar Companies

Alpha Med Thrift Co

Alpha Med Thrift Co is a Orland Park, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Receivable Solutions

Receivable Solutions is a national provider of revenue cycle management (“RCM”) services to hospitals and health systems. Through its client-focused culture, RSi delivers accounts receivable management and revenue cycle outsourcing services to accelerate provider cash flow, improve operating efficiencies and enhance profitability without sacrificing patient experience. The Company`s solutions span the full RCM continuum, providing both point solutions to address specific client challenges and full end-to-end RCM outsourcing. RSi was founded in 1999 and is headquartered in Columbia, South Carolina.

Mectra Labs

Mectra Labs is a Bloomfield, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Visante Incorporated

High-performing pharmacy is who we are At Visante, we believe in moving healthcare forward through innovative solutions that deliver lasting results. For over 20 years, we`ve been advancing the business of pharmacy™ by helping our clients deliver compliant services and products that foster growth and improve patient care. Our firm focuses on three areas of medication management: hospitals and health systems, pharmaceutical industry and managed care/government programs. Integrated health networks (IDNs), hospitals and health systems know us for our expertise to maximize lasting growth in 340B programs, specialty pharmacy, pharmacy assessments, sterile compounding and drug diversion. In addition, through our partner PharmacyStars, we provide a platform of technology solutions for our hospital and health system clients to maximize compliance in the areas of 340B, sterile compounding, drug diversion and more. Our managed care and government programs experts are here to help you navigate complex, changing requirements to reach compliance goals. Specializing in Medicare Parts C and D consulting, we can help you prepare for audits by the Centers for Medicare and Medicaid Services (CMS), conduct mock audits, improve operations, and maintain compliance. No matter how complex your compliance issues and operational needs are, we`re here to implement quality, cost-effective solutions. Visante consists of more than 60 consultants across the U.S., Canada, and the U.K., all working together to provide expert guidance from a wide range of disciplines, including pharmacy, nursing, operations, and information technology. We`re here to move the practice of pharmacy in the right direction.

Enterin Inc.

Enterin is pioneering the medical community`s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease. We are leveraging years of research to become the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha- synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson`s disease. In the gut, this results in improved motility. We are now progressing this drug through clinical trials in an attempt to reverse the constipation of Parkinson`s disease. Our long-term mission is to become the world leader in developing pharmaceutical therapies that repair the gut-brain axis.